Fosbait (Fosrenol)250MG – 30 tablet

$16.10

Each Fosbait contains 250 mg Lanthanum Carbonate 30 tablets used to prevent and treat high blood phosphate levels in patients with severe kidney diseases.

ATC Classification: V03AE03
Active Ingrediant: Lanthanum
Generic Name: Fosbait
Manufacturer: Pancea Biotec
Strength: 250MG
Dosage Type: Tablet Chewable
Packaging Type: Bottle in Box
Contains: 30 Tab

 

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
Fosbait (Fosrenol)250MG – 30 tablet
$16.10

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Lanthanum Information


What is this drug used for?

• It is used to lower high phosphate levels.

 

Possible side effects

Lanthanum may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• Diarrhea.
• Belly pain.
• Upset stomach or throwing up.

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Very bad belly pain.
• Very bad constipation.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Lanthanum may be confused with lithium

 

Storage and Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from moisture. Do not open oral powder until ready to use.

 

Adverse Reactions

>10%:

Gastrointestinal: Diarrhea (oral powder: ≤18%; chewable tablets: ≤7%), nausea (oral powder: ≤18%; chewable tablet: ≤11%), vomiting (oral powder: ≤18%; chewable tablets: ≤9%)

1% to 10%:

Endocrine & metabolic: Hypocalcemia (5%)

Gastrointestinal: Abdominal pain (chewable tablet: 5%)

<1%, postmarketing, and/or case reports: Accidental injury (tooth injury with chewable tablets), allergic skin reaction, constipation, dyspepsia, fecal impaction, gastrointestinal perforation, hypophosphatemia, intestinal obstruction (including ileus and subileus), intestinal perforation –

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , ,

Strength

Dosage Type

Packaging Type